Hyperbaric oxygenation as a therapeutic method in experimental subacute and chronic peripheral circulatory disturbances.
D000818:Animals; D004195:Disease Models, Animal; D004878:Ergotamine; D004983:Ethanolamines / Q000627:therapeutic use; D005734:Gangrene / Q000139:chemically induced / Q000628:therapy*; D006931:Hyperbaric Oxygenation; D007511:Ischemia; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D051381:Rats; D012039:Regional Blood Flow; D014652:Vascular Diseases / Q000628:therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D004983:Ethanolamines; D009539:Nicotinic Acids; D010276:Parasympatholytics; D014665:Vasodilator Agents; D010208:Papaverine; D004878:Ergotamine